ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Duke recruits Judd Moul as chief of urology.

July 9, 2004

CREG Announcement June 1 Includes 17 Projects Worth $4.1 Million

May 16, 1975

In Brief: Peter Greenwald A Leading Candidate For One Of Three Top NCI Jobs Remaining To Be Filled

August 7, 1981

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

NCI Would Get More Money For AIDs Under Heckler Proposal, But Most Would Come Out Of Construction

August 2, 1985

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005